Olivier Rixe

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 5.8K citations · Full text

Medicine, Oncology, Pharmacology +14

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel

Olivier Rixe, Waldo Ortuzar, Manuel Álvarez et al. · Biochemical Pharmacology · 1996 · 615 citations

Medicine, Oncology, Pharmacology +15

Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management

Vincent Launay‐Vacher, Stéphane Oudard, Nicolas Janus et al. · Cancer · 2007 · 455 citations

Pharmacy, Oncology, Pharmacotherapy +17

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

Olivier Rixe, Ronald M. Bukowski, M. Dror Michaelson et al. · The Lancet Oncology · 2007 · 436 citations

Medicine, Oncology, Pharmacology +14

Surgical margins in cutaneous melanoma (2 cm <i>versus</i> 5 cm for lesions measuring less than 2.1‐mm thick)

David Khayat, Olivier Rixe, G. Martin et al. · Cancer · 2003 · 277 citations

Medicine, Dermatology, Surgery +17